China SXT Pharmaceuticals Inc (SXTC) — Cash Flow Quality Index
China SXT Pharmaceuticals Inc (SXTC) has a Cash Flow Quality Index of -13.83x as of June 2026. Operating cash flow of $-2.26 Million is below net income of $163.72K, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow to debt ratio of China SXT Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China SXT Pharmaceuticals Inc Cash Flow Quality Index (2016–2019)
Historical Cash Flow Quality Index for China SXT Pharmaceuticals Inc across 4 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does China SXT Pharmaceuticals Inc generate cash.
Annual Cash Flow Quality Index for China SXT Pharmaceuticals Inc (2016–2019)
Year-by-year earnings quality comparison for China SXT Pharmaceuticals Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2019 | 0.16x | $239.19K | $1.54 Million | ▼ -90.4% |
| 2018 | 1.62x | $1.92 Million | $1.19 Million | ▲ +553.9% |
| 2017 | 0.25x | $293.04K | $1.19 Million | ▼ -80.8% |
| 2016 | 1.29x | $182.47K | $141.54K | — |